Clinical Medicine • Calcium & Bone Physiology

Parathyroidectomy Explained: Indications, Surgical Approaches, Intraoperative PTH and Postoperative Complications

Diagnosis first, localization second, surgery third—and postoperative mineral physiology determines what comes next.

Dr. Seneth Gajasinghe, MBBS, MD Updated September 11, 2026 40 min read

Diagnosis first → localization second → surgery third

Parathyroidectomy is the surgical removal of one or more parathyroid glands or of abnormal parathyroid tissue.

PARATHYROID SURGERY STARTS WITH BIOCHEMISTRY AND ENDS WITH BIOCHEMISTRY

Parathyroidectomy showing surgical removal of hyperfunctioning parathyroid tissue followed by a fall in PTH.
Parathyroidectomy showing surgical removal of hyperfunctioning parathyroid tissue followed by a fall in PTH.
Comparison of focused parathyroidectomy subtotal parathyroidectomy and total parathyroidectomy with autotransplantation.
Comparison of focused parathyroidectomy subtotal parathyroidectomy and total parathyroidectomy with autotransplantation.

What Is Parathyroidectomy?

Core Teaching Question

When should parathyroidectomy be performed, how does the surgical approach differ between primary and renal hyperparathyroidism, how can intraoperative PTH help assess gland removal, and how should postoperative hypocalcemia and other complications be interpreted?

Central Teaching Framework

CONFIRM THE DIAGNOSIS IS SURGERY INDICATED? LOCALIZE FOR SURGERY CHOOSE THE APPROPRIATE OPERATION REMOVE HYPERFUNCTIONING TISSUE ASSESS PTH RESPONSE MONITOR Ca + PO₄ + Mg + PTH IDENTIFY POSTOPERATIVE COMPLICATIONS CONFIRM LONG-TERM CURE

Memory statement:

DIAGNOSIS FIRST → LOCALIZATION SECOND → SURGERY THIRD

Opening Content

Use the following complete text.

Parathyroidectomy is the surgical removal of one or more parathyroid glands or of abnormal parathyroid tissue.

It is the definitive treatment for many patients with primary hyperparathyroidism and has an important role in selected patients with severe secondary or tertiary hyperparathyroidism.

However:

PARATHYROIDECTOMY IS NOT ONE IDENTICAL OPERATION FOR EVERY FORM OF HYPERPARATHYROIDISM

In sporadic primary hyperparathyroidism, the problem is commonly a single abnormal gland.

In renal secondary and tertiary hyperparathyroidism, the disease more commonly involves multiple hyperplastic glands.

Therefore the operation must be matched to:

  • the underlying diagnosis;
  • expected glandular pathology;
  • preoperative localization;
  • previous neck surgery;
  • hereditary disease where relevant;
  • the patient's renal and clinical context.

The decision to operate must begin with the biochemical diagnosis, not with an abnormal imaging result.

Parathyroid imaging is principally used to determine where abnormal parathyroid tissue is located before an operation that has already been indicated.

After surgery, calcium may fall.

That postoperative fall has several possible explanations.

Two particularly important mechanisms are:

HUNGRY BONE SYNDROME

and:

POSTSURGICAL HYPOPARATHYROIDISM

Understanding parathyroidectomy therefore requires more than knowing how a gland is removed.

The complete pathway is:

DIAGNOSIS → INDICATION → LOCALIZATION → OPERATION → BIOCHEMICAL RESPONSE → POSTOPERATIVE PHYSIOLOGY → LONG-TERM FOLLOW-UP

What Are The Parathyroid Glands?

Most people have four parathyroid glands, usually located close to the posterior surface of the thyroid gland.

However, parathyroid anatomy is variable.

Glands may occur in ectopic locations because of their embryological migration.

This matters during surgery because abnormal parathyroid tissue may sometimes be found in locations such as:

  • the thymic region;
  • mediastinum;
  • retroesophageal locations;
  • intrathyroidal locations;
  • other ectopic cervical sites.

Supernumerary glands may also occur.

Therefore:

FAILED LOCALIZATION OF AN ABNORMAL GLAND DOES NOT MEAN THE BIOCHEMICAL DIAGNOSIS IS WRONG

and:

ANATOMICAL VARIATION MATTERS IN PERSISTENT DISEASE

What Does Parathyroidectomy Try To Achieve?

The surgical goal depends on the disease.

Primary hyperparathyroidism

Goal:

REMOVE THE AUTONOMOUS ABNORMAL PARATHYROID TISSUE

while preserving sufficient normal parathyroid function.

Severe renal secondary hyperparathyroidism

Goal:

REDUCE EXCESSIVE MULTIGLAND PTH SECRETION

when severe disease cannot be adequately controlled medically.

Tertiary hyperparathyroidism

Goal:

CONTROL PERSISTENT AUTONOMOUS HYPERPLASTIC PARATHYROID TISSUE

especially when clinically important hypercalcemia or other complications persist.

Thus:

SAME ORGAN — DIFFERENT DISEASE — DIFFERENT SURGICAL STRATEGY

Confirm the Diagnosis Before Surgery

First Rule: Establish The Diagnosis Before Surgery

Use a prominent warning box:

DO NOT OPERATE ON AN IMAGE

A sestamibi-positive or ultrasound-positive lesion does not independently establish hyperparathyroidism.

Before surgery, first establish the physiological diagnosis.

Ask:

WHAT IS THE CALCIUM? WHAT IS THE PTH? WHAT IS THE PHOSPHATE? WHAT IS THE RENAL FUNCTION? WHAT IS THE CLINICAL CONTEXT?

Then determine whether the patient has:

  • primary hyperparathyroidism;
  • renal secondary hyperparathyroidism;
  • tertiary hyperparathyroidism;
  • another PTH-related disorder.

A Critical Preoperative Mistake: Fhh

A patient with:

Ca ↑ + PTH NONSUPPRESSED

does not automatically have primary hyperparathyroidism requiring surgery.

Familial hypocalciuric hypercalcemia can produce a similar biochemical pattern.

FHH generally does not correct with ordinary parathyroidectomy.

Therefore an inappropriate operation can expose the patient to surgical risk while leaving the hypercalcemia essentially unchanged.

Use:

BEFORE PHPT SURGERY → EXCLUDE IMPORTANT MIMICS WHEN CLINICALLY INDICATED

Familial Hypocalciuric Hypercalcemia

Indications for Parathyroidectomy

Indications For Parathyroidectomy In Phpt

Parathyroidectomy is the definitive treatment for primary hyperparathyroidism.

Symptomatic patients should generally be offered surgery unless medically contraindicated.

For asymptomatic PHPT, the 2022 Fifth International Workshop recommends surgery when one or more recognized criteria are present. (OUP Academic)

Use the following table.

DomainSurgical criterion
Serum calcium>1.0 mg/dL (0.25 mmol/L) above the upper limit of normal
SkeletalVertebral fracture by VFA or vertebral imaging
Bone densityT-score ≤ −2.5 at any site
Renal functioneGFR or creatinine clearance <60 mL/min
Renal imagingNephrolithiasis or nephrocalcinosis
Hypercalciuria>250 mg/day in women or >300 mg/day in men
Age<50 years

Immediately below:

ONLY ONE CRITERION IS REQUIRED

Age below 50 years is itself sufficient under these guidelines.

Surgery can also be considered in patients who do not meet these specific criteria if they prefer definitive treatment, provided there is agreement with the treating physician and no contraindication. (OUP Academic)

Primary Hyperparathyroidism

Symptomatic Phpt

Examples of clinically important manifestations include:

  • nephrolithiasis;
  • nephrocalcinosis;
  • skeletal disease/fracture;
  • clinically important hypercalcemia.

The key teaching principle is:

SURGERY IS NOT RESERVED ONLY FOR EXTREME HYPERCALCEMIA

Patients can have important renal or skeletal disease even when calcium elevation is relatively modest.

Age Under 50 Years

Use a specific memory box:

PHPT + AGE <50 YEARS = SURGICAL CRITERION

No additional renal, skeletal or calcium criterion is required under the Fifth International Workshop recommendations. (OUP Academic)

The criterion is:

<50 YEARS

Normocalcemic Phpt

Normocalcemic PHPT requires:

  • persistently elevated PTH;
  • repeatedly normal total/adjusted and ionized calcium;
  • exclusion of secondary causes.

The Fifth International Workshop concluded that evidence was insufficient to establish specific surgical guidelines for normocalcemic PHPT.

Therefore:

DO NOT AUTOMATICALLY APPLY THE HYPERCALCEMIC PHPT SURGICAL CRITERIA AS A FORMAL NPHPT GUIDELINE

Management should be individualized.

Normocalcemic Primary Hyperparathyroidism

Parathyroidectomy In Renal Secondary Hpt

This is a different disease.

In CKD:

CKD-MBD CHRONIC PARATHYROID STIMULATION SECONDARY HPT

Most patients are managed medically.

But some develop severe refractory disease.

KDIGO suggests parathyroidectomy in patients with:

CKD G3a–G5D + SEVERE HPT

that:

FAILS TO RESPOND TO MEDICAL / PHARMACOLOGICAL THERAPY (KDIGO)

Therefore:

DO NOT USE ONE PTH NUMBER AS THE UNIVERSAL SURGICAL TRIGGER

Consider the complete disease pattern and response to therapy.

Internal links:

Secondary Hyperparathyroidism

CKD-MBD

Why Renal Hpt Surgery Differs

Sporadic PHPT is frequently caused by one abnormal gland.

Renal secondary HPT commonly causes:

MULTIGLAND HYPERPLASIA

Therefore a focused single-gland operation that may be appropriate for a well-localized solitary PHPT adenoma is not automatically appropriate for severe renal HPT.

The surgical strategy must reflect the expected biology.

Tertiary Hpt And Surgery

Tertiary hyperparathyroidism represents acquired autonomous or poorly suppressible PTH secretion after prolonged secondary HPT.

A classic context is persistent hypercalcemic HPT after successful kidney transplantation.

Surgery may be considered when clinically important autonomous disease remains:

  • persistent;
  • hypercalcemic;
  • symptomatic or complicated;
  • inadequately controlled by appropriate medical therapy.

Tertiary Hyperparathyroidism

Parathyroid Localization

Imaging Comes After The Decision For Surgery

BIOCHEMISTRY TELLS YOU WHETHER THE PATIENT HAS HYPERPARATHYROIDISM IMAGING HELPS TELL THE SURGEON WHERE TO OPERATE

Therefore:

DIAGNOSIS ≠ LOCALIZATION

Imaging should generally be performed when surgery is planned, rather than being used as a screening test to determine whether hyperparathyroidism exists.

Ultrasound

Neck ultrasound can help identify enlarged parathyroid glands and simultaneously assess thyroid anatomy.

Advantages include:

  • no ionizing radiation;
  • availability;
  • anatomical information;
  • thyroid assessment.

Limitations include:

  • operator dependence;
  • ectopic glands;
  • small lesions;
  • multigland disease;
  • difficulty distinguishing some thyroid and lymph-node lesions.

Sestamibi Imaging

Technetium-99m sestamibi-based imaging can help localize hyperfunctioning parathyroid tissue.

It may be combined with:

SPECT/CT

to provide functional plus anatomical localization.

Its performance can be reduced in:

  • small abnormal glands;
  • multigland disease;
  • some hyperplastic glands.

Again:

NEGATIVE SESTAMIBI DOES NOT EXCLUDE PHPT

4D-Ct And Additional Localization

4D-CT can provide detailed anatomical and perfusion-related localization, particularly in selected patients such as:

  • discordant conventional imaging;
  • previously operated necks;
  • difficult localization.

Other advanced localization techniques may be used in specialist centers.

The teaching point is:

MORE DIFFICULT ANATOMY → MORE SPECIALIZED LOCALIZATION MAY BE NEEDED

Concordant Imaging

When two localization studies identify the same likely solitary abnormal gland in an appropriate PHPT patient:

FOCUSED PARATHYROIDECTOMY MAY BE POSSIBLE

But:

CONCORDANT IMAGING DOES NOT CHANGE THE BIOCHEMICAL DIAGNOSIS

It changes operative planning.

What If Imaging Is Negative?

Use:

NEGATIVE IMAGING ≠ NO DISEASE

A patient with biochemically established PHPT can still have surgically treatable disease despite negative localization.

Potential approaches include:

  • additional localization when appropriate;
  • bilateral neck exploration by an experienced parathyroid surgeon.

The operation should not be cancelled solely because a localization study is negative if there is a valid surgical indication.

Surgical Approaches

Focused Parathyroidectomy

Focused or minimally invasive parathyroidectomy limits dissection to the suspected abnormal gland or region.

It is most suitable when:

  • biochemical PHPT is established;
  • preoperative localization suggests a solitary abnormal gland;
  • multigland disease is not strongly suspected.

Advantages can include:

  • smaller dissection;
  • shorter operation in appropriate cases;
  • less tissue disruption.

However:

THE OPERATION MUST STILL ACHIEVE BIOCHEMICAL CURE

AAES guidance supports intraoperative PTH monitoring when an image-guided focused operation is used because imaging alone can miss multigland disease. (JAMA Network)

Bilateral Neck Exploration

Bilateral exploration allows the surgeon to evaluate all expected parathyroid glands.

It may be particularly useful when:

  • localization is negative;
  • imaging is discordant;
  • multigland disease is suspected;
  • hereditary disease is present;
  • previous information suggests more than one abnormal gland;
  • operative findings do not match localization.

The goal is not simply:

FIND FOUR GLANDS

The goal is:

IDENTIFY AND APPROPRIATELY TREAT ALL HYPERFUNCTIONING TISSUE WHILE PRESERVING NECESSARY PARATHYROID FUNCTION

Why Multigland Disease Matters

A focused operation assumes that the localized gland explains the hyperparathyroidism.

If another hyperfunctioning gland remains:

PTH MAY REMAIN EXCESSIVE

and:

SURGERY MAY FAIL

Therefore multigland disease is one reason intraoperative PTH monitoring can be useful during focused PHPT surgery. (JAMA Network)

Renal-Hpt Surgical Approaches

Severe secondary and tertiary renal HPT commonly involve multiple glands.

Common conceptual approaches include:

Subtotal parathyroidectomy

Most hyperfunctioning parathyroid tissue is removed while a small vascularized remnant is intentionally preserved.

Total parathyroidectomy with autotransplantation

Parathyroid tissue is removed from the neck and a selected small amount is transplanted to another site.

The objective is to balance:

CONTROL OF EXCESSIVE PTH

against:

AVOIDING PERMANENT COMPLETE PARATHYROID DEFICIENCY

Is Subtotal Or Total Ptx With Autotransplantation Better?

A 2025 meta-analysis of tertiary HPT involving 28 studies and approximately 1,000 patients found broadly similar hypercalcemia cure, recurrence, complications and biochemical control between subtotal PTX and total PTX with autotransplantation. (PubMed)

Therefore:

SURGICAL APPROACH SHOULD BE INDIVIDUALIZED

according to:

  • disease;
  • anatomy;
  • renal/transplant context;
  • surgeon expertise;
  • institutional practice.

What Is Autotransplantation?

Autotransplantation means placing a small amount of viable parathyroid tissue into another anatomical site after removal from the neck.

The intention is to retain some parathyroid function while removing the major hyperfunctioning gland burden.

A potential advantage of an accessible autograft site is that recurrent hyperfunction from grafted tissue may be easier to evaluate or address than deep cervical tissue.

However, autotransplanted tissue can itself become hyperfunctional.

Therefore:

AUTOTRANSPLANTATION DOES NOT ELIMINATE THE POSSIBILITY OF RECURRENT HPT

Intraoperative PTH Monitoring

Intraoperative Pth Monitoring

This should be a major teaching section.

PTH has a short circulating half-life.

Therefore after successful removal of the major source of excessive PTH:

PTH SHOULD FALL RAPIDLY

Intraoperative PTH monitoring uses this physiological property to provide real-time biochemical information during surgery.

AAES guidance particularly supports its use with image-guided focused parathyroidectomy. (JAMA Network)

Basic Intraoperative Pth Sequence

Display:

BASELINE / PRE-EXCISION PTH REMOVE SUSPECTED ABNORMAL GLAND REPEAT PTH AFTER EXCISION

Appropriate decline

HYPERFUNCTIONING SOURCE LIKELY REMOVED

Inadequate decline

CONSIDER ADDITIONAL HYPERFUNCTIONING TISSUE CONTINUE ASSESSMENT / EXPLORATION AS APPROPRIATE

Miami Criterion

This can be taught because it is a widely used intraoperative PTH protocol, but it must not be presented as the only valid protocol.

The classic Miami criterion generally uses:

>50% PTH FALL

from the highest pre-incision or pre-excision value:

10 MINUTES AFTER EXCISION

of the presumed hyperfunctioning gland.

Meeting the criterion supports adequate removal of hypersecreting tissue.

However:

MIAMI IS A PROTOCOL — NOT A UNIVERSAL LAW OF PARATHYROID BIOLOGY

Other validated intraoperative PTH protocols exist.

AAES recommends that surgeons using intraoperative PTH employ a reliable local protocol and understand PTH decay dynamics. (JAMA Network)

Why Pth May Not Fall Appropriately

Possible explanations include:

  • another hyperfunctioning gland;
  • multigland disease;
  • incorrect gland removed;
  • delayed PTH clearance;
  • sampling/timing issues;
  • assay-related issues.

Renal impairment can alter PTH kinetics and interpretation.

Therefore:

INTRAOPERATIVE PTH MUST BE INTERPRETED IN CLINICAL CONTEXT

Intraoperative Pth Does Not Replace Surgical Judgment

Use:

IOPTH = ADJUNCT, NOT AUTOPILOT

It complements:

  • preoperative diagnosis;
  • imaging;
  • operative anatomy;
  • surgeon assessment.

A numerical result should not be interpreted without understanding the procedure and disease.

What Happens After Parathyroidectomy?

What Happens To Pth After Successful Surgery?

In PHPT, removal of the autonomous source should cause:

PTH ↓ RAPIDLY

Over subsequent hours and days, calcium physiology begins adjusting to the new hormonal state.

In severe renal HPT, the fall may be dramatic because the preoperative PTH burden can be very high.

The consequences depend partly on the preoperative skeleton.

Why Calcium Falls After Surgery

Potential contributors include:

  • sudden reduction in PTH;
  • skeletal mineral uptake;
  • transient impairment of remaining parathyroid tissue;
  • permanent parathyroid insufficiency;
  • magnesium abnormalities.

Therefore:

POSTOPERATIVE Ca ↓ IS A FINDING — NOT THE FINAL DIAGNOSIS

The Essential Postoperative Question

Ca ↓ AFTER PARATHYROIDECTOMY

Ask:

WHAT IS THE PO₄? WHAT IS THE PTH? WHAT IS THE Mg? WAS PREOPERATIVE BONE TURNOVER HIGH?

This converts postoperative hypocalcemia from a memorization problem into a physiological diagnostic problem.

Hungry Bone Syndrome

After prolonged severe hyperparathyroidism:

BONE TURNOVER ↑↑

After successful parathyroidectomy:

PTH ↓ BONE RESORPTION ↓

while mineralization continues.

Ca + PO₄ + Mg → BONE PROLONGED HYPOCALCEMIA

Typical clues include:

Ca ↓ PO₄ ↓ often Mg ↓ may occur PREOPERATIVE ALP ↑ often

This is:

HUNGRY BONE SYNDROME

Hungry Bone Syndrome Explained

Postsurgical Hypoparathyroidism

A different mechanism is insufficient PTH.

Remember:

LOW Ca SHOULD MAKE PTH RISE

Therefore:

Ca ↓ + PTH LOW / INAPPROPRIATELY NORMAL

suggests inadequate parathyroid function.

Phosphate is typically:

PO₄ ↑

because PTH-dependent renal phosphate excretion is reduced.

Hypoparathyroidism Explained

Hbs Vs Postoperative Hypopt

FeatureHungry bone syndromePostsurgical hypoparathyroidism
Calcium
PTHVariable/context-dependentLow/inappropriately normal
PhosphateOften ↓Usually ↑
MagnesiumMay ↓May ↓/normal
Preoperative ALPOften ↑Not required
High-turnover bone diseaseImportant clueNot required
MechanismMinerals entering boneInsufficient PTH
DurationCan be prolongedTransient or chronic

Bottom:

SAME LOW CALCIUM — DIFFERENT PHYSIOLOGY

Can Both Mechanisms Coexist?

Yes.

A patient can have:

  • major skeletal mineral uptake;
  • impaired postoperative parathyroid function;

at the same time.

Therefore real postoperative biochemical patterns may not always fit perfectly into one textbook box.

Use serial:

Ca + PO₄ + Mg + PTH

and clinical context.

Diagnostic pathway for hypocalcemia after parathyroidectomy distinguishing hungry bone syndrome from postsurgical hypoparathyroidism.
Diagnostic pathway for hypocalcemia after parathyroidectomy distinguishing hungry bone syndrome from postsurgical hypoparathyroidism.

Postoperative Monitoring and Complications

Postoperative Monitoring

Depending on the operation and risk profile, postoperative assessment may include:

  • symptoms;
  • serum calcium;
  • ionized calcium when clinically useful;
  • phosphate;
  • magnesium;
  • PTH;
  • renal function.

High-risk HBS patients may require substantially closer biochemical surveillance than uncomplicated low-risk PHPT patients.

Symptoms Requiring Urgent Attention

Significant hypocalcemia can produce:

  • perioral paresthesia;
  • distal tingling;
  • muscle cramps;
  • carpopedal spasm;
  • tetany;
  • seizures;
  • QT prolongation;
  • arrhythmia.

Severe symptomatic hypocalcemia requires urgent assessment and calcium treatment.

Hypocalcemia

Neck Hematoma

Postoperative neck bleeding can produce an expanding hematoma.

This matters because expansion within the neck can threaten:

THE AIRWAY

Warning features can include:

  • rapidly increasing neck swelling;
  • respiratory difficulty;
  • voice change;
  • stridor;
  • swallowing difficulty;
  • pressure/tightness.

Use a strong callout:

EXPANDING POSTOPERATIVE NECK HEMATOMA = AIRWAY EMERGENCY

This is a surgical emergency requiring immediate assessment and management.

Recurrent Laryngeal Nerve Injury

The recurrent laryngeal nerves are anatomically close to the thyroid/parathyroid operative field.

Injury can affect vocal-cord function.

Possible manifestations include:

  • hoarseness;
  • weak voice;
  • swallowing symptoms;
  • airway problems in severe bilateral injury.

Persistent postoperative voice change warrants appropriate assessment.

Other Operative Risks

Briefly include:

  • infection;
  • seroma;
  • anesthetic complications;
  • scar-related issues;
  • injury to nearby structures.

The endocrine-specific postoperative physiology should remain the article's emphasis.

Cure, Persistent and Recurrent PHPT

What Does Surgical Cure Mean In Phpt?

For hypercalcemic PHPT, cure is conventionally defined by restoration of normal calcium homeostasis for at least:

6 MONTHS

after parathyroidectomy. (PubMed Central (PMC))

This six-month point also helps distinguish:

PERSISTENT

from:

RECURRENT

PHPT.

Persistent Phpt

Use the accepted definition:

PERSISTENT PHPT

means hypercalcemia:

  • continues after surgery;

or:

  • returns within the first 6 months after parathyroidectomy.

Potential causes include:

  • missed abnormal gland;
  • unrecognized multigland disease;
  • ectopic gland;
  • supernumerary gland;
  • incomplete resection.

(PubMed Central (PMC))

Recurrent Phpt

Use:

RECURRENT PHPT

means hypercalcemia returns:

AFTER >6 MONTHS OF DOCUMENTED NORMOCALCEMIA

following initially successful surgery. (PubMed Central (PMC))

Possible explanations include:

  • recurrent growth of abnormal tissue;
  • previously unrecognized multigland disease;
  • new hyperfunctioning tissue.

Important Pth Nuance After Surgery

A patient may have:

NORMAL Ca + HIGH PTH

after successful surgery.

Possible secondary explanations include:

  • vitamin D deficiency;
  • renal impairment;
  • low calcium intake;
  • other secondary HPT causes.

ESE consensus emphasizes that isolated PTH elevation with normocalcemia does not itself meet the definition of recurrent PHPT. (PubMed Central (PMC))

Therefore:

RECURRENT PHPT REQUIRES RECURRENT HYPERCALCEMIA

in the usual hypercalcemic-PHPT framework.

Evaluating Failed Surgery

Before considering reoperation:

RECONFIRM THE ORIGINAL DIAGNOSIS

Then review:

  • previous calcium/PTH results;
  • previous imaging;
  • operative report;
  • pathology;
  • intraoperative PTH data;
  • postoperative biochemical course.

Then obtain high-quality localization appropriate to the reoperative setting.

Why?

Because:

REOPERATIVE PARATHYROID SURGERY IS MORE DIFFICULT

and carries greater risk than initial surgery. (PubMed Central (PMC))

Do Not Reoperate Casually

Use a warning box:

FAILED FIRST OPERATION ≠ AUTOMATIC SECOND OPERATION

Before reoperation:

CONFIRM DIAGNOSIS CONFIRM INDICATION LOCALIZE ABNORMAL TISSUE REVIEW PREVIOUS OPERATIVE INFORMATION SPECIALIST REOPERATIVE PLANNING

Histopathology and Long-Term Outcomes

Histopathology

Pathological findings can include:

  • parathyroid adenoma;
  • multigland hyperplasia;
  • atypical parathyroid tumor;
  • parathyroid carcinoma.

In sporadic PHPT, solitary adenoma is common, while renal HPT more often involves multigland hyperplasia. AAES guidance notes that approximately 85% of PHPT patients have a solitary adenoma. (JAMA Network)

However:

PATHOLOGY DOES NOT REPLACE THE PREOPERATIVE BIOCHEMICAL DIAGNOSIS

Parathyroid Carcinoma

Keep brief.

Consider carcinoma in an appropriate clinical context of unusually severe PHPT, particularly when accompanied by features suggesting invasive parathyroid malignancy.

Management differs from ordinary adenoma surgery and requires specialist endocrine surgical care.

This should eventually be a separate article if the cluster expands into parathyroid neoplasia.

What Happens To Bone After Successful Phpt Surgery?

Successful correction of PTH excess can allow:

BONE TURNOVER TO NORMALIZE

and bone mineral density can improve over time in many patients.

In severe high-turnover disease, the immediate skeletal response may instead produce:

HUNGRY BONE SYNDROME

Thus the skeletal response after surgery ranges from gradual recovery to profound acute mineral uptake depending on preoperative disease severity.

What Happens To Kidney-Stone Risk?

Parathyroidectomy corrects the PTH-driven hypercalcemic state in successfully treated PHPT and can reduce the biochemical drivers of stone formation.

However:

SURGERY DOES NOT ERASE EVERY OTHER STONE RISK FACTOR

Patients with recurrent stones may still require appropriate metabolic stone assessment.

Long-Term Follow-Up

Even after apparently successful surgery, long-term biochemical follow-up remains important because recurrence can occur years later.

ESE consensus recommends long-term yearly calcium monitoring after successful PHPT surgery because recurrence may occur late. (PubMed Central (PMC))

Follow-up should be adapted to:

  • disease;
  • surgery;
  • biochemical findings;
  • renal status;
  • recurrence risk.

Master Surgical Pathway

HYPERPARATHYROIDISM CONFIRM BIOCHEMICAL DIAGNOSIS

PHPT?

→ exclude important mimics such as FHH when indicated.

SURGICAL INDICATION? LOCALIZATION

US ± sestamibi/SPECT-CT ± selected advanced imaging

Likely solitary disease

FOCUSED PTX ± IOPTH

Multigland / negative / discordant localization

BILATERAL EXPLORATION AS APPROPRIATE

Severe renal SHPT?

Failed appropriate medical/pharmacological therapy

PARATHYROIDECTOMY

using appropriate multigland strategy.

Tertiary HPT?

Persistent clinically significant autonomous disease

medical vs surgical management

PARATHYROIDECTOMY WHEN APPROPRIATE

After any major PTX:

MONITOR Ca + PO₄ + Mg + PTH

Ca ↓ + PO₄ ↓ + high-turnover history

HUNGRY BONE

Ca ↓ + PO₄ ↑ + PTH ↓

HYPOPARATHYROIDISM LONG-TERM BIOCHEMICAL FOLLOW-UP

Worked Clinical Cases

Case 1 — Symptomatic PHPT

Patient has:

  • hypercalcemia;
  • nonsuppressed PTH;
  • recurrent renal stones.

Interpretation

PHPT WITH A SURGICAL INDICATION

Localization is performed for operative planning, not to establish the diagnosis.

Case 2 — Asymptomatic but calcium criterion met

Patient has confirmed PHPT.

Serum calcium is:

1.2 mg/dL ABOVE THE UPPER LIMIT OF NORMAL

No stones and no fracture.

Interpretation

SURGICAL CRITERION MET

Only one criterion is required.

Case 3 — Young patient

Patient aged 38 years has confirmed PHPT but otherwise relatively mild disease.

Interpretation

AGE <50 YEARS IS ITSELF A SURGICAL CRITERION

Case 4 — Negative localization

Patient has unequivocal biochemical PHPT and meets surgical criteria.

Ultrasound and sestamibi are negative.

Wrong conclusion

“No parathyroid disease.”

Correct interpretation

IMAGING LOCALIZES — IT DOES NOT DIAGNOSE

Referral to an experienced parathyroid surgeon remains appropriate.

Case 5 — FHH mistaken for PHPT

Patient has:

  • lifelong mild hypercalcemia;
  • nonsuppressed PTH;
  • very low urinary calcium;
  • family history of similar hypercalcemia.

Principle

CONSIDER FHH BEFORE SURGERY

Parathyroidectomy generally does not correct the underlying FHH physiology.

Case 6 — Severe renal secondary HPT

Dialysis patient has severe persistent HPT despite appropriate medical/pharmacological management.

Interpretation

PARATHYROIDECTOMY MAY BE APPROPRIATE

The decision is not based on one isolated PTH value. (KDIGO)

Case 7 — Tertiary HPT

Patient with years of severe renal SHPT receives a successful kidney transplant but continues to have:

  • hypercalcemia;
  • excessive PTH;
  • clinically important persistent disease despite appropriate medical management.

Principle

PARATHYROIDECTOMY MAY PROVIDE DEFINITIVE CONTROL

Case 8 — Appropriate intraoperative PTH fall

Patient undergoing focused PTX has:

  • high pre-excision PTH;
  • localized gland removed;
  • > 50% PTH decline by the protocol's appropriate post-excision measurement.

Interpretation

BIOCHEMICAL EVIDENCE SUPPORTS ADEQUATE REMOVAL

provided the locally validated intraoperative protocol is satisfied.

Case 9 — Inadequate intraoperative PTH decline

Localized gland is removed but PTH does not fall appropriately.

Consider

ADDITIONAL HYPERFUNCTIONING TISSUE

including multigland disease.

Also consider sampling, timing and clearance issues.

Lesson

DO NOT IGNORE THE PHYSIOLOGY

Case 10 — Hungry bone syndrome

Patient had:

  • severe HPT;
  • very high ALP;
  • major skeletal disease.

After PTX:

  • Ca ↓↓↓;
  • PO₄ ↓;
  • Mg ↓.

Interpretation

HUNGRY BONE SYNDROME

The skeleton is rapidly taking up mineral.

Case 11 — Postsurgical hypoparathyroidism

After neck surgery:

  • Ca ↓;
  • PO₄ ↑;
  • PTH very low.

Interpretation

POSTSURGICAL HYPOPARATHYROIDISM

not classic hungry bone syndrome.

Case 12 — Recurrent PHPT

Patient became normocalcemic after successful surgery and remained so for more than six months.

Several years later:

  • hypercalcemia returns;
  • PTH is nonsuppressed.

Interpretation

RECURRENT PHPT

Reconfirm the diagnosis and localize carefully before considering reoperation. (PubMed Central (PMC))

Common Mistakes

Include all 20.

Mistake 1

A positive sestamibi scan diagnoses PHPT.

Wrong.

Mistake 2

Negative localization excludes PHPT.

Wrong.

Mistake 3

Every PHPT patient needs all surgical criteria.

Wrong. One criterion is sufficient.

Mistake 4

Age must be ≤50 years.

Wrong. The current criterion is <50 years.

Mistake 5

Only symptomatic PHPT should be operated on.

Wrong.

Mistake 6

Every high PTH in CKD requires parathyroidectomy.

Wrong.

Mistake 7

Renal SHPT surgery is triggered by one universal PTH number.

Wrong.

Mistake 8

Sporadic PHPT and renal HPT usually require the same operation.

Wrong.

Mistake 9

All PHPT is caused by one adenoma.

Wrong.

Mistake 10

Focused surgery cannot miss multigland disease.

Wrong.

Mistake 11

Intraoperative PTH replaces surgical judgment.

Wrong.

Mistake 12

The Miami criterion is the only valid intraoperative PTH protocol.

Wrong.

Mistake 13

Every calcium fall after PTX means hypoparathyroidism.

Wrong.

Mistake 14

Every postoperative calcium fall is hungry bone syndrome.

Wrong.

Mistake 15

Phosphate is irrelevant to postoperative hypocalcemia.

Wrong.

Mistake 16

Magnesium can be ignored.

Wrong.

Mistake 17

Normal calcium with elevated PTH automatically means recurrent PHPT.

Wrong.

Mistake 18

Persistent and recurrent PHPT mean the same thing.

Wrong.

Mistake 19

Reoperation should proceed without reconfirming diagnosis/localization.

Wrong.

Mistake 20

Successful surgery eliminates the need for long-term follow-up.

Wrong.

Parathyroidectomy in One Minute

One-Minute Revision

PARATHYROIDECTOMY IN ONE MINUTE

BIOCHEMICAL DIAGNOSIS SURGICAL INDICATION LOCALIZATION

Solitary PHPT likely

FOCUSED PTX

or:

Multigland / renal HPT

BROADER MULTIGLAND SURGERY INTRAOPERATIVE PTH

when appropriate

PTH SHOULD FALL POSTOPERATIVE Ca?

Ca stable

→ routine follow-up

Ca ↓

CHECK PO₄ + PTH + Mg

PO₄ ↓ + high-turnover bone

HUNGRY BONE

PO₄ ↑ + PTH ↓

HYPOPARATHYROIDISM CONFIRM LONG-TERM CURE

Golden Rules

Display near the end.

RULE 1 DIAGNOSE BIOCHEMICALLY — LOCALIZE RADIOLOGICALLY RULE 2 ONE PHPT SURGICAL CRITERION IS ENOUGH RULE 3 THE OPERATION MUST MATCH THE DISEASE RULE 4 PTH SHOULD FALL AFTER THE HYPERFUNCTIONING SOURCE IS REMOVED RULE 5 LOW Ca AFTER SURGERY IS NOT A DIAGNOSIS RULE 6 PO₄ + PTH HELP SEPARATE HUNGRY BONE FROM HYPOPARATHYROIDISM RULE 7 PERSISTENT = WITHIN 6 MONTHS RECURRENT = AFTER >6 MONTHS OF NORMOCALCEMIA

Frequently Asked Questions

What is parathyroidectomy?

Parathyroidectomy is surgery to remove one or more abnormal or hyperfunctioning parathyroid glands or portions of parathyroid tissue.

Is parathyroidectomy the definitive treatment for PHPT?

Yes. Parathyroidectomy is the definitive treatment for primary hyperparathyroidism and is recommended when appropriate surgical indications are present.

Does every PHPT patient need surgery?

Not necessarily. However, surgery is recommended for symptomatic disease and for asymptomatic patients meeting at least one recognized surgical criterion; it may also be chosen by other appropriate patients who prefer definitive treatment and have no contraindication.

Does a positive sestamibi scan diagnose PHPT?

No. PHPT is a biochemical diagnosis. Sestamibi and other imaging studies are primarily used to localize abnormal tissue for surgery.

Can surgery still be performed if imaging is negative?

Yes. Negative localization does not exclude biochemically confirmed PHPT. An experienced parathyroid surgeon may use additional localization or bilateral exploration when appropriate.

What is focused parathyroidectomy?

It is a limited operation directed at a localized abnormal gland, most applicable when sporadic PHPT appears to arise from a solitary lesion.

What is bilateral neck exploration?

It is an operative approach that allows systematic assessment of the parathyroid glands and is particularly useful when multigland disease is suspected or localization is negative or discordant.

What is intraoperative PTH monitoring?

It measures the rapid fall in circulating PTH after abnormal parathyroid tissue is removed and can help determine whether sufficient hyperfunctioning tissue has been excised.

What is the Miami criterion?

The classic Miami criterion uses a greater than 50% decline in PTH from the highest pre-incision or pre-excision value approximately 10 minutes after excision of the suspected hyperfunctioning gland. Other validated protocols also exist.

Why does calcium fall after parathyroidectomy?

Possible causes include expected physiological adjustment, hungry bone syndrome, transient or persistent hypoparathyroidism, and magnesium-related abnormalities.

How can hungry bone syndrome be distinguished from hypoparathyroidism?

HBS commonly produces low calcium with low phosphate in a high-bone-turnover context, whereas postsurgical hypoparathyroidism typically produces low calcium, high phosphate and low or inappropriately normal PTH.

When is parathyroidectomy used in renal secondary HPT?

KDIGO suggests surgery for severe hyperparathyroidism in CKD G3a–G5D when appropriate medical or pharmacological treatment has failed.

What is persistent PHPT after surgery?

Persistent PHPT means hypercalcemia continues or returns within the first six months after parathyroidectomy.

What is recurrent PHPT?

Recurrent PHPT is the return of hypercalcemia after more than six months of documented normocalcemia following initially successful surgery.

Is high PTH with normal calcium after surgery automatically recurrence?

No. Secondary causes of elevated PTH should be assessed. Recurrent hypercalcemic PHPT is defined by recurrent hypercalcemia, not isolated PTH elevation.

Key Take-Home Messages

Parathyroidectomy is not simply the removal of a gland seen on a scan.

The process begins with:

PHYSIOLOGY

First determine:

WHY IS PTH HIGH?

and:

WHAT IS THE CALCIUM?

Only after the biochemical diagnosis is established should the clinician ask:

IS SURGERY INDICATED?

In primary hyperparathyroidism, surgery may be required because of symptoms, hypercalcemia, skeletal involvement, renal involvement, hypercalciuria or young age.

In renal secondary hyperparathyroidism, the principle is different:

SEVERE DISEASE + FAILURE OF APPROPRIATE MEDICAL THERAPY

may lead to parathyroidectomy.

In tertiary hyperparathyroidism, surgery can provide definitive control of persistent clinically important autonomous parathyroid tissue.

Once surgery has been selected:

IMAGING LOCALIZES

but:

IMAGING DOES NOT DIAGNOSE

A well-localized solitary PHPT lesion may permit focused parathyroidectomy.

Multigland disease may require broader exploration.

Renal hyperparathyroidism commonly requires a multigland strategy such as subtotal parathyroidectomy or total parathyroidectomy with autotransplantation.

During selected operations:

INTRAOPERATIVE PTH

provides real-time biochemical evidence of whether the major hyperfunctioning source has been removed.

But the operation is not finished conceptually when the gland leaves the neck.

The next question is:

WHAT HAPPENS TO CALCIUM?

If calcium falls:

DO NOT IMMEDIATELY LABEL THE PATIENT HYPOPARATHYROID

Instead ask:

PO₄? PTH? Mg? PREOPERATIVE BONE TURNOVER?

Then distinguish:

HUNGRY BONE SYNDROME

from:

POSTSURGICAL HYPOPARATHYROIDISM

Finally, successful surgery requires long-term biochemical confirmation.

Therefore the complete parathyroidectomy pathway is:

DIAGNOSIS INDICATION LOCALIZATION APPROPRIATE OPERATION PTH RESPONSE POSTOPERATIVE MINERAL PHYSIOLOGY LONG-TERM CURE

Final memory statement:

PARATHYROID SURGERY STARTS WITH BIOCHEMISTRY AND ENDS WITH BIOCHEMISTRY